Billionaire Asness’ Secret Formula Points To Apple, Microsoft, and Pfizer
AQR Capital Management is predominantly a quantitative equity hedge fund firm, co-founded by former Goldman Sachs portfolio manager Clifford S. Asness in 1997.
Posts Tagged ‘Pfizer Inc (PFE)’
Billionaire Leon Cooperman’s Top New Stocks ~ Humana Inc (HUM), Targa Resources Corp (TRGP), HRG Group Inc. (HRG)
Omega Advisors Inc. is a New York-based hedge fund founded by one of the most respected figures in the investment business, Leon Cooperman.
Cliff Asness’ Long Term Holdings
AQR Capital Management LLC was founded in 1998 by former Goldman Sachs portfolio manager Cliff Asness.
Billionaire Paul Tudor Jones’ Top Picks Include Automatic Data Processing Inc. (ADP), NCR Corporation (NCR)
Tudor Investment Corporation, the brainchild of Paul Tudor Jones, is a Greenwich, Connecticut-based hedge fund that uses a mix of fundamental and quantitative analysis accompanied...
Healthcare Stocks Poised To Explode? Billionaire Investors Are Betting On These
Insider Monkey strives to always keep investors updated on diverse stocks across different industries.
5 Most Popular Healthcare Stocks Among Hedge Funds
According to a recent study by CIT, a reputable firm that is involved in financing and advisory services to the healthcare sector, healthcare executives seem rather optimistic...
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Citigroup Inc (C) Top Kahn Brothers’ Portfolio
Kahn Brothers Advisors LLC is an Investment Advisor company providing brokerage and money management services to clients.
Apple Inc. (AAPL), Pfizer Inc., and Wells Fargo & Co (WFC) Got A Vote of Confidence From Billionaire Ken Fisher
Ken Fisher is one of the most popular American investors, Forbes columnist since 1984, and the author of the eleven investment books, four of which are New York Times Best Sellers...
Apple Inc. (AAPL), Pfizer Inc. (PFE), Wells Fargo & Co (WFC): Billionaire Ken Fisher Bets on Tech, Healthcare and Finance Heading into Q2
Billionaire Ken Fisher is the CEO of Fisher Asset Management, a fund with around $50.05 billion in equities as of the end of March. Mr.
Sprott Inc’s Tech Picks: Apple Inc. (AAPL), Verizon Communications Inc. (VZ) & More
Billionaire Eric Sprott's investing reputation is rooted in precious metals.
Pfizer Inc. (PFE), Anthem Inc (ANTM), Aetna Inc (AET): Swedish Fund, Healthinvest’s Top Bullish Picks In First Quarter
Anders Hallberg and Carl Bennet's healthcare-focused fund, Healthinvest Partners AB, recently disclosed its equity holdings in a 13F filing with the Securities and Exchange Commission...
Dorset Management Made a Bundle By Betting on Biotech and Energy; More Profits to Come?
David M. Knott’s Dorset Management seems to have had an excellent start to the year.
Conatus Pharmaceuticals Inc (CNAT): Healthcor Takes Large Stake; See Conatus’ Needham Healthcare Conference Presentation Inside
Healthcor Management LP, managed by Arthur B. Cohen and Joseph P.
Pfizer Inc. (PFE) Helped Kahn Brothers Beat the Market Despite BlackBerry Ltd (BBRY) Losses
Kahn Brothers, managed by Alan Kahn and Thomas Kahn managed to beat the market in the first quarter of 2015, a period during which the fund’s co-founder and longtime manager...
Big Losses in BlackBerry Ltd (BBRY) Weigh on Prem Watsa’s Fairfax Financial; Picks Lost 8% in Q1
Prem Watsa’s Fairfax Financial Holdings is having a tough start for 2015.
Apple Inc. (AAPL), Pfizer Inc. (PFE): Billionaire Ken Fisher’s Picks Slightly Beat The Market
Ken Fisher’s Fisher Asset Management boasts a massive portfolio, with the fund having 422 long positions in companies with a market cap of at least $1 billion at the end of ...
Actavis plc (ACT), Valeant Pharmaceuticals Intl Inc (VRX) & More: Top Healthcare Picks Among Hedge Funds Crushed Mr. Market
The first quarter of 2015 is over and before hedge funds start releasing their Form 13F filings over the next 45 days, we will take a look at the performance of the stocks they...
Hedge Funds Made A Bundle By Betting On Amazon.com, Inc. (AMZN), Apple, and Pfizer Inc
As we are entering into the second quarter of 2015, it's time to take a brief look back and see how the market performed during the first three months of the year, and most importantly...
Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD): Sabby Capital’s Latest Moves in Healthcare Sector
Hal Mintz's Sabby Capital has initiated a passive stake in Superconductor Technologies, Inc. (NASDAQ:SCON) according to a schedule 13G form filed with the SEC.
Billionaire Ken Fisher’s Top Long-Term Picks: Pfizer Inc., Visa Inc., and More
Billionaire Ken Fisher’s Fisher Asset Management maintains a broad and diversified equity portfolio consisting primarily of long positions.
ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday's intraday trading and hit a 52-week high of $46.48.
Hedge Funds Are Crazy About These Dow Stocks
A popular misconception is that since these companies are in the business of finding the most value for their clients, the overwhelming experience of the fund managers, and considering...
Hedge Funds Are Crazy About These Five Dow Jones Dividend Leaders
Tracking the activity of hedge funds is a great way to identify profitable investments that will help you beat the market.
Mallinckrodt PLC (MNK), Pfizer Inc. (PFE): Healthcor Management’s Top 5 Health Stocks
Arthur B. Cohen and Joseph Healey’s Healthcor Management LP recently filed its latest 13F with the SEC, disclosing its equity positions at the end of 2014.
Kahn Brothers’ Top Picks to Close 2014, as Founder Irving Kahn Passes at 109
Irving Kahn, the oldest active investor on Wall Street, died this week at age 109.
Apple Inc. (AAPL) is 14% Overvalued, S&P 500 16%: Canadian Fund Manager
Toronto-based Trapeze Asset Management says Apple Inc. (NASDAQ:AAPL) is 14% overvalued according to its proprietary valuation models. Pfizer Inc.
10 Most Popular Healthcare Stocks Among Hedge Funds
With the business of analyzing and compiling the data of our 737 tracked hedge funds’ latest 13F filings behind us, we’re ready to start sharing some of the findings from ...
Zoetis Inc (ZTS) Avoids Possible Fight By Adding Two Members From Activist Side
Animal health care company, Zoetis Inc (NYSE:ZTS) is doing extremely well according to activist investor Bill Ackman of Pershing Square, having agreed to add two members to the...
Funds Reveal New Positions in Peabody Energy Corporation (BTU), BIND Therapeutics Inc (BIND)
Two of our tracked funds have recently revealed in filings with the SEC that they’ve taken large new passive positions in a couple of stocks.
Epirus Biopharmaceuticals Inc (EPRS): These Two Funds Open New Positions
The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over.
Pfizer Inc. (PFE), Alliance HealthCare Services, Inc. (AIQ), Skilled Healthcare Group, Inc. (SKH): HealthInvest Partners AB’s Largest Holdings Last Quarter
Anders Hallberg and Carl Bennet’s HealthInvest Partners AB revealed its top picks for the fourth quarter of 2014. According to the 13F Form filed with the U.S.
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) Round 2; START
The pharmaceutical industry was the focus of intense debate earlier this year owing to potential merger between Pfizer Inc. (NYSE:PFE) and AstraZeneca plc (ADR) (NYSE:AZN).
Actavis plc (ACT), Allergan, Inc. (AGN), Pfizer Inc. (PFE): Hedge Funds Betting Big on Healthcare Stocks
One of the sectors that has benefited from the highest returns over the years is Healthcare.
American Express Company (AXP), Wells Fargo & Co (WFC), Pfizer Inc. (PFE): Stock Ken Fisher is Most Bullish On
Generally, big investors with multi-billion dollar portfolios wait until the last possible date to release their 13F filing, which is not the case for Ken Fisher.
The 10 Top Best-Selling Products of All Time
Top best-selling products of all time: Some products come and go without much impact on society, yet others sell so well that they remain in our memories forever.
Actavis plc (ACT) Manipulating Patients to Use New Alzheimer’s Drug: NY AG’s Office
Actavis plc (NYSE:ACT) is in hot water with the New York Attorney General’s office over practices they feel are manipulative of patients.
Apple Inc. (AAPL), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Among AQR Capital Management’s Top Q2 Picks
AQR Capital Management, managed by Cliff Asness, recently published its 13F filing with the U.S. Securities and Exchange Commission for the second quarter of 2014.
The Boeing Company (BA), Pfizer Inc. (PFE), The Procter & Gamble Company (PG): Matthew Tewksbury’s Top 3 Picks For the Second Quarter
Matthew Tewksbury’s Stevens Capital Management recently disclosed, with the SEC, its long equity positions for the second quarter of 2014.
Pfizer Inc. (PFE) To Sweeten Bid for Astrazeneca plc (ADR) (AZN): Frost & Sullivan
Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while Merck & Co., Inc.
How Pharma Majors like Pfizer Inc. (PFE), Johnson & Johnson (JNJ) And Merck & Co. Inc. (MRK) Are Responding To Alzheimer?
CNBC's Meg Tirrell reported on the popular “Squawk Box” program that patients suffering from Alzheimer disease in U.S and across the globe are assuming epidemic proportions...
Fisher Asset Management’s Top Picks From The Latest 13F: American Express Company (AXP), Amazon.com, Inc. (AMZN) & Others
In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last year.
Investing in Counteracting Biological and Chemical Agents
Chemical nerve agents have garnered much media coverage recently, but receiving less attention are the companies involved in the development of countermeasures to these and biological...
Nektar Therapeutics (NKTR), Pfizer Inc. (PFE): What’s MannKind Corporation (MNKD) Really Worth?
This is close to the market cap that Bank of America's Steve Byrne thinks MannKind Corporation (NASDAQ:MNKD) is worth.
AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
Bank of America Corp (BAC), American International Group Inc (AIG): When a Crisis Became a Catastrophe
Lehman Brothers filed for bankruptcy protection early in the morning on Sept. 15, 2008, after failing to find any company willing to acquire its immense liabilities.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ): Top Risk Factors for Heart Disease
Heart disease is the leading cause of death in the United States. In 2010, according to data from the Centers for Disease Control and Prevention, 597,689 people in the U.S.
Trius Therapeutics, Inc. (TSRX), Cubist Pharmaceuticals Inc (CBST), Pfizer Inc. (PFE): A Portfolio Of Potential
After the market closed on July 30, antibiotic expert Cubist Pharmaceuticals Inc (NASDAQ:CBST) announced two acquisitions worth up to a combined $1.6 billion.
Amgen, Inc. (AMGN), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): The Neulasta Question
In a couple of years, Amgen, Inc. (NASDAQ:AMGN) will have to face the music when the patent for its $4 billion a year drug, Neulasta, expires in the U.S. and Europe.
MannKind Corporation (MNKD), Pfizer Inc. (PFE): Why Afrezza May Not Work
MannKind Corporation (NASDAQ:MNKD) has been struggling to get its inhalable insulin product Afrezza on the market; the product was sent back to the labs by the Food and Drug Administration...
Ariad Pharmaceuticals, Inc. (ARIA), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does This Orphan Leukemia Treatment Have Blockbuster Potential?
When most biotech investors think of cancer treatments, they tend to think of large established players like Roche and Amgen.
